Voyager Therapeutics, Inc. (VYGR) Capital expenditures 2016–2025
Voyager Therapeutics, Inc. (VYGR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.6MFY2025 · since FY2016: $5.0M → $2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.6M | -26.3% |
| FY2024 | $3.5M | +8.1% |
| FY2023 | $3.3M | +30.7% |
| FY2022 | $2.5M | +54.8% |
| FY2021 | $1.6M | -86.7% |
| FY2020 | $12.1M | +56.7% |
| FY2019 | $7.7M | +79.3% |
| FY2018 | $4.3M | +8.0% |
| FY2017 | $4.0M | -20.8% |
| FY2016 | $5.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice